Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Express Scripts
AstraZeneca
Mallinckrodt
McKesson

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for TAK-733

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug TAK-733: Sponsors, patents, clinical trial progress

TAK-733 is an investigational drug.

There have been 314 clinical trials for TAK-733. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2018.

The most common disease conditions in clinical trials are Diabetes Mellitus, Hypertension, and Diabetes Mellitus, Type 2. The leading clinical trial sponsors are Takeda, Millennium Pharmaceuticals, Inc., and National Cancer Institute (NCI).

Recent Clinical Trials for TAK-733
TitleSponsorPhase
A Pharmacokinetic and Safety Study of TAK-925 in Participants With Idiopathic HypersomniaMillennium Pharmaceuticals, Inc.Phase 1
A Study of TAK-994 in Participants With Narcolepsy Type 1TakedaPhase 1
Intratumoral Microdosing of TAK-981 in Head and Neck CancerTakedaEarly Phase 1

See all TAK-733 clinical trials

Clinical Trial Summary for TAK-733

Top disease conditions for TAK-733
Top clinical trial sponsors for TAK-733

See all TAK-733 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
AstraZeneca
Baxter
Mallinckrodt
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.